Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,6813,700 of 20,252 grants

Active TRAINING, INDIVIDUAL
HMGB1 in EB-Associated Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2027

Project Summary/Abstract Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disease characterized by chronic wounds and shortened lifespan due to a high incidence...

$416.1K
USD
Active TRAINING, INDIVIDUAL
Elucidating mechanisms of therapy response in BRCA2 mutant prostate cancers
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2026

ABSTRACT Prostate cancer is the most common non-skin malignancy in men and is projected to cause 34,500 deaths in 2022 in the United States alone. Sequencing studies of advanced le...

$384.3K
USD
Active NON-SBIR/STTR RPGS
HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2028

PROJECT SUMMARY Lung cancer is the leading cause of cancer related deaths in the United States and the World. We recently demonstrated that programmed cell death 1 (PD-1) inhibitor...

$6.21M
USD
Active NON-SBIR/STTR RPGS
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

Summary Prostate cancer (PCa) is the most commonly diagnosed cancer and the second leading cause of cancer death in American males. Androgen deprivation therapies and androgen rece...

$5.13M
USD
Active NON-SBIR/STTR RPGS
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Clearly identified barriers have undermined the promise of immunotherapy for pediatric patients with solid or brain tumors. Most of these tumors lack genet...

$8.6M
USD
Active NON-SBIR/STTR RPGS
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Lung cancer is the leading cause of cancer death in the United States, and lung cancer screening has been demonstrated to effectively reduce lung cancer by...

$5.6M
USD
Active NON-SBIR/STTR RPGS
RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2023 – 2028

Project Summary/Abstract As the death toll from cervical cancer continues to rise, particularly in low-resource settings, we are in search of more effective approaches to cervical...

$5.11M
USD
Active NON-SBIR/STTR RPGS
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

Lineage plasticity has emerged as an important mechanism of treatment resistance in prostate cancer that results into multiple different tumor states. Recent classifications effort...

$5.5M
USD
Completed OTHER RESEARCH-RELATED
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
NATIONAL CANCER INSTITUTE Federation of Amer Soc for Exper Biology United States 2023 – 2024

Project Summary/Abstract Cholangiocarcinoma (CCA) is a macro-molecularly diverse hepato-biliary tract malignancy that accounts for approximately 3.0% of gastrointestinal malignanci...

$140K
USD
Active TRAINING, INDIVIDUAL
Mitochondrial Regulation of Interferon Response in Melanoma
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2026

PROJECT SUMMARY Interferons (IFNs) are central orchestrators of tumor immunity and can elicit both pro-tumor and anti-tumor responses depending on the cancer cell type, the type of...

$405.2K
USD
Active NON-SBIR/STTR RPGS
Vascular regulation of fatty acid transport in metastatic tumor outgrowth
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2023 – 2028

Project Summary Tumor metastasis requires supportive microenvironment for outgrowth of disseminated tumor cells. The switch of metastatic cells from dormant to proliferative state...

$5.06M
USD
Active RESEARCH CENTERS
University of California and UT Southwestern D-PDTC
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The University of California and the University of Texas Southwestern (UCaTS) Diversity Patient-Derived Xenograft (PDX) Development and Trial Center’s is a...

$10.61M
USD
Active RESEARCH CENTERS
Admin Core
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The overall goal of this application is to establish and characterize a large collection of minority patient-derived cancer xenografts (PDXs) from two canc...

Active RESEARCH CENTERS
PDX Core
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The primary objectives of the Patient Derived Xenograft (PDX) Core will be to establish and characterize PDXs, and to support the research aims of the two...

Active RESEARCH CENTERS
Bioinformatics Core
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY The overall objective of the proposed Diversity PDX Development and Testing Center (D-PDTC) is directed at improving cancer precision medicine approaches for gastri...

Active RESEARCH CENTERS
Advancing gastric cancer precision medicine in Latinos through patient-derived modeling
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY/ASTRACT Gastric cancer (GC) is a leading cause of cancer incidence, mortality, and survival disparities in Latinos, the largest and youngest U.S. minority and the l...

Active RESEARCH CENTERS
Characterizing treatment responses for common lung cancer (LC) subtypes in Latinos and Asians
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

SPECIFIC AIMS The purpose of UCaTS Project 2 is to target clinically important genomic markers of early resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in EGFR-mutant non...

Active RESEARCH CENTERS
Pilot Projects and Trans-Network Activities
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PILOT PROJECTS AND TRANS-NETWORK ACTIVITIES CORE University of California and UT Southwestern Diversity Patient-Derived Xenograft (PDX) Development and Trial Center (UCaTS) to Redu...

Active NON-SBIR/STTR RPGS
Utilizing Multi-omics to Facilitate Cancer Biology Research
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

Project Summary As a member of the E. Alejandro Sweet-Cordero laboratory my efforts are directed at executing the computational aspects of the grants, manuscripts, and the general...

$2.34M
USD
Active NON-SBIR/STTR RPGS
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
NATIONAL CANCER INSTITUTE Veterans Education/Res/Assn/North/Ne United States 2023 – 2028

Project Summary There are ~800,000 bladder cancer survivors in the US, making it the fifth most prevalent cancer. This study focuses on the largest group of patients with bladder c...

$5.84M
USD